Metabolic syndrome: from epidemiology to systems biology

Metabolic syndrome (MetSyn) is a group of metabolic conditions that occur together and promote the development of cardiovascular disease (CVD) and diabetes. Recent genome-wide association studies have identified several novel susceptibility genes for MetSyn traits, and studies in rodent models have provided important molecular insights. However, as yet, only a small fraction of the genetic component is known. Systems-based approaches that integrate genomic, molecular and physiological data are complementing traditional genetic and biochemical approaches to more fully address the complexity of MetSyn.

[1]  V. Mootha,et al.  Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. , 2007, The Journal of clinical investigation.

[2]  A. Garg,et al.  Genetic disorders of adipose tissue development, differentiation, and death. , 2006, Annual review of genomics and human genetics.

[3]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[4]  P. Gluckman.  Evolving a definition of disease , 2007, Archives of Disease in Childhood.

[5]  M. McCarthy,et al.  Regulation of Fto/Ftm gene expression in mice and humans. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[7]  M. Link,et al.  Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP. , 2008, The Journal of clinical investigation.

[8]  C. Kahn,et al.  Evidence for a role of developmental genes in the origin of obesity and body fat distribution. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  F. Malone,et al.  Human sexual size dimorphism in early pregnancy. , 2007, American journal of epidemiology.

[10]  R. Balling.  From mouse genetics to systems biology , 2007, Mammalian Genome.

[11]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[12]  John D. Storey,et al.  Mapping the Genetic Architecture of Gene Expression in Human Liver , 2008, PLoS biology.

[13]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[14]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[15]  C. Glass,et al.  Maternal Hypercholesterolemia During Pregnancy Promotes Early Atherogenesis in LDL Receptor-Deficient Mice and Alters Aortic Gene Expression Determined by Microarray , 2002, Circulation.

[16]  M. Rieder,et al.  Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations , 2008, Diabetes.

[17]  A. Attie,et al.  The genetic landscape of type 2 diabetes in mice. , 2007, Endocrine reviews.

[18]  Eric E. Schadt,et al.  Integrating genetic and gene expression data: application to cardiovascular and metabolic traits in mice , 2006, Mammalian Genome.

[19]  J C Stanley,et al.  The glucose-fatty acid cycle. Relationship between glucose utilization in muscle, fatty acid oxidation in muscle and lipolysis in adipose tissue. , 1981, British journal of anaesthesia.

[20]  M. McCarthy,et al.  Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.

[21]  Subhajyoti De,et al.  Common variants near MC4R are associated with fat mass, weight and risk of obesity , 2008, Nature Genetics.

[22]  G. Anantharamaiah,et al.  The role of high-density lipoprotein in inflammation. , 2005, Trends in cardiovascular medicine.

[23]  P. Elliott,et al.  Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides , 2008, Nature Genetics.

[24]  H. Lodish,et al.  Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. , 2004, The Journal of clinical investigation.

[25]  J. Silha,et al.  Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. , 2004, Obesity research.

[26]  Nathan R. Qi,et al.  Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension , 2008, Nature Genetics.

[27]  Philippe Froguel,et al.  Common genetic variation near MC4R is associated with waist circumference and insulin resistance , 2008, Nature Genetics.

[28]  Aldons J. Lusis,et al.  A thematic review series: systems biology approaches to metabolic and cardiovascular disorders , 2006, Journal of Lipid Research.

[29]  E. Yilmaz,et al.  Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes , 2006, Science.

[30]  E. Nisoli,et al.  A critical reflection on the definition of metabolic syndrome. , 2006, Pharmacological research.

[31]  P. Gluckman,et al.  Living with the Past: Evolution, Development, and Patterns of Disease , 2004, Science.

[32]  J L Witztum,et al.  Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. , 1997, The Journal of clinical investigation.

[33]  Swneke D. Bailey,et al.  Genetic Variants of FTO Influence Adiposity, Insulin Sensitivity, Leptin Levels, and Resting Metabolic Rate in the Quebec Family Study , 2008, Diabetes.

[34]  K. Nakao,et al.  Role of premature leptin surge in obesity resulting from intrauterine undernutrition. , 2005, Cell metabolism.

[35]  A. Tchernof,et al.  Androgens and body fat distribution , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[36]  S. Horvath,et al.  Variations in DNA elucidate molecular networks that cause disease , 2008, Nature.

[37]  E. Schadt,et al.  Genetic and Genomic Analysis of a Fat Mass Trait with Complex Inheritance Reveals Marked Sex Specificity , 2006, PLoS genetics.

[38]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[39]  E. Abel,et al.  Reduced Mitochondrial Oxidative Capacity and Increased Mitochondrial Uncoupling Impair Myocardial Energetics in Obesity , 2005, Circulation.

[40]  S. Brietzke.  Controversy in diagnosis and management of the metabolic syndrome. , 2007, The Medical clinics of North America.

[41]  W. G. Hill,et al.  Heritability in the genomics era — concepts and misconceptions , 2008, Nature Reviews Genetics.

[42]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[43]  P. Elliott,et al.  Common Variation in the FTO Gene Alters Diabetes-Related Metabolic Traits to the Extent Expected Given Its Effect on BMI , 2008, Diabetes.

[44]  H. Stefánsson,et al.  Genetics of gene expression and its effect on disease , 2008, Nature.

[45]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[46]  M. Garaulet,et al.  Body fat distribution in pre-and post-menopausal women: metabolic and anthropometric variables. , 2002, The journal of nutrition, health & aging.

[47]  Elliott J. Meer,et al.  Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. , 2008, The Journal of clinical investigation.

[48]  M. Patti,et al.  The emerging genetic architecture of type 2 diabetes. , 2008, Cell metabolism.

[49]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[50]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Sekar Kathiresan,et al.  Defining the spectrum of alleles that contribute to blood lipid concentrations in humans , 2008, Current opinion in lipidology.

[52]  J. Castle,et al.  An integrative genomics approach to infer causal associations between gene expression and disease , 2005, Nature Genetics.

[53]  G. Reaven.  Banting lecture 1988 , 1997 .

[54]  D. Strachan,et al.  LDL-cholesterol concentrations: a genome-wide association study , 2008, The Lancet.

[55]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[56]  E. Schadt,et al.  Identification of Abcc6 as the major causal gene for dystrophic cardiac calcification in mice through integrative genomics , 2007, Proceedings of the National Academy of Sciences.

[57]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[58]  Jonathan C. Cohen,et al.  Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes , 2008, Human molecular genetics.

[59]  Martin Adiels,et al.  Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[60]  T. Frayling,et al.  New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function , 2008, Current opinion in clinical nutrition and metabolic care.

[61]  D. Severson,et al.  What are the Biochemical Mechanisms Responsible for Enhanced Fatty Acid Utilization by Perfused Hearts from Type 2 Diabetic db/db Mice? , 2008, Cardiovascular Drugs and Therapy.

[62]  G. Fonarow,et al.  An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. , 2007, American heart journal.

[63]  Olga Ilkayeva,et al.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.

[64]  S. Grundy,et al.  The metabolic syndrome , 2003, The Lancet.

[65]  D. Ron,et al.  Endoplasmic reticulum stress signaling in disease. , 2006, Physiological reviews.

[66]  Richard N Bergman,et al.  Why Visceral Fat is Bad: Mechanisms of the Metabolic Syndrome , 2006, Obesity.

[67]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[68]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[69]  K. Petersen,et al.  Decreased Insulin-Stimulated ATP Synthesis and Phosphate Transport in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Parents , 2005, PLoS medicine.

[70]  Dong-Ho Han,et al.  High-fat diets cause insulin resistance despite an increase in muscle mitochondria , 2008, Proceedings of the National Academy of Sciences.

[71]  A. Giacca,et al.  Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo. , 2007, The Journal of endocrinology.

[72]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[73]  James Strait,et al.  Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits , 2007, PLoS genetics.

[74]  I. Tabas.  Apoptosis and efferocytosis in mouse models of atherosclerosis. , 2007, Current drug targets.

[75]  Edwin Cuppen,et al.  Progress and prospects in rat genetics: a community view , 2008, Nature Genetics.

[76]  F. Liu,et al.  Regulation of Insulin Action by Ceramide , 2004, Journal of Biological Chemistry.

[77]  Dudley J Pennell,et al.  Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass , 2008, Nature Genetics.

[78]  Christopher B. Newgard,et al.  Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[79]  Margaret F. Gregor,et al.  Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease Published, JLR Papers in Press, May 9, 2007. , 2007, Journal of Lipid Research.

[80]  V. Mootha,et al.  Abnormal glucose homeostasis in skeletal muscle–specific PGC-1α knockout mice reveals skeletal muscle–pancreatic β cell crosstalk , 2007 .

[81]  B. Nordestgaard,et al.  Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. , 2004, The Journal of clinical investigation.

[82]  Erling Falk,et al.  Plaque rupture in humans and mice. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[83]  D. Barker.  The developmental origins of well-being. , 2004, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[84]  R. Leboeuf,et al.  LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. , 2002, American journal of physiology. Endocrinology and metabolism.

[85]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[86]  B. Kahn,et al.  Chronic free fatty acid infusion in rats results in insulin resistance but no alteration in insulin-responsive glucose transporter levels in skeletal muscle , 1996, Lipids.

[87]  E. Petretto,et al.  Integrated gene expression profiling and linkage analysis in the rat , 2006, Mammalian Genome.

[88]  P. Libby,et al.  Pathophysiology of Coronary Artery Disease , 2005, Circulation.

[89]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[90]  M. Laakso,et al.  Downregulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance , 2008, Cell.

[91]  S. Grundy.  Metabolic Syndrome Pandemic , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[92]  R. D'Agostino,et al.  A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study , 2007, BMC Medical Genetics.

[93]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[94]  S. Subramanian,et al.  Dietary Cholesterol Worsens Adipose Tissue Macrophage Accumulation and Atherosclerosis in Obese LDL Receptor–Deficient Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[95]  Merlin C. Thomas,et al.  Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes , 2008, Diabetes.

[96]  D. Lawlor,et al.  Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. , 2008, The Journal of clinical investigation.

[97]  M. Lazar,et al.  How Obesity Causes Diabetes: Not a Tall Tale , 2005, Science.

[98]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[99]  Elias Chaibub Neto,et al.  Genetic Networks of Liver Metabolism Revealed by Integration of Metabolic and Transcriptional Profiling , 2008, PLoS genetics.

[100]  Philipp W. Raess,et al.  Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus , 2006, Nature Genetics.

[101]  R. Kahn.  Metabolic Syndrome: Is It a Syndrome? Does It Matter? , 2007, Circulation.

[102]  L. Orci,et al.  Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome , 2008, Proceedings of the National Academy of Sciences.

[103]  Aiqing He,et al.  The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[104]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[105]  W. Hsueh,et al.  Recipes for creating animal models of diabetic cardiovascular disease. , 2007, Circulation research.

[106]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[107]  Aiqing He,et al.  Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids , 2006, Proceedings of the National Academy of Sciences.

[108]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[109]  R. Singer,et al.  STEATOPYGIA: THE FATTY ACID COMPOSITION OF SUBCUTANEOUS ADIPOSE TISSUE IN THE HOTTENTOT. , 1963, American journal of physical anthropology.

[110]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[111]  J. Tegnér,et al.  Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Multi-organ whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits Published, JLR Papers in Press, December 1, 2006. , 2007, Journal of Lipid Research.

[112]  T. Reinehr,et al.  Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach , 2007, Archives of Disease in Childhood.

[113]  Zachary A. Szpiech,et al.  Genotype, haplotype and copy-number variation in worldwide human populations , 2008, Nature.

[114]  Y. Pao,et al.  Pleiotropy, homeostasis, and functional networks based on assays of cardiovascular traits in genetically randomized populations. , 2003, Genome research.

[115]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[116]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[117]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.

[118]  Philippe Pibarot,et al.  Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[119]  D. Giannella‐Neto,et al.  Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[120]  A. Arnold,et al.  Are XX and XY brain cells intrinsically different? , 2004, Trends in Endocrinology & Metabolism.

[121]  S. Devaskar,et al.  Histone Code Modifications Repress Glucose Transporter 4 Expression in the Intrauterine Growth-restricted Offspring* , 2008, Journal of Biological Chemistry.

[122]  D. Stoffers,et al.  Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. , 2008, The Journal of clinical investigation.

[123]  D. James,et al.  Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment , 2008, Diabetologia.

[124]  W. Soeller,et al.  Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide. , 2007, American journal of physiology. Endocrinology and metabolism.

[125]  J. Edwards.  The genetic basis of common disease , 1963 .

[126]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[127]  J. Weiss,et al.  Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Network perspectives of cardiovascular metabolism Published, JLR Papers in Press, August 31, 2006. , 2006, Journal of Lipid Research.

[128]  M. Wolters,et al.  Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. , 2009, Atherosclerosis.

[129]  S. Horvath,et al.  Evidence for anti-Burkitt tumour globulins in Burkitt tumour patients and healthy individuals. , 1967, British Journal of Cancer.

[130]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[131]  G. Sweeney,et al.  Cardiac remodeling in obesity. , 2008, Physiological reviews.

[132]  Richard A. King,et al.  The genetic basis of common diseases. , 2002 .

[133]  S. Kahn,et al.  Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.

[134]  J. Speakman.  A nonadaptive scenario explaining the genetic predisposition to obesity: the "predation release" hypothesis. , 2007, Cell metabolism.

[135]  Yuji Yamamoto,et al.  Beneficial effects of subcutaneous fat transplantation on metabolism. , 2008, Cell metabolism.

[136]  Jean Tichet,et al.  A Polymorphism Within the G6PC2 Gene Is Associated with Fasting Plasma Glucose Levels , 2008, Science.

[137]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.